Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

0.00%

4.1¢ incannex healthcare limited

Ann: Official Supplier and Research Partner - ONE Championship, page-51

First 51 Last

Share
Profile

Follow
MrFantastic

2,844 Posts.

1248

02/08/19

15:54

Post #: 39835266
Share

Originally posted by Exalted: ↑

I got no issue with you Jackson, I am often a contrarian and welcome contrarian views. Social Media can often be mindnumbingly pumpy or biased at times but generally would like any negative posts to come with genuine analysis, but hey its always easy to say something in a one-liner and walk away with no skin in the game.

This BOD is great, Widdows, Valentine and now Dr Sud make up a fantastic team to send us into the stratosphere. The mouth guard dental biz is not the greatest I will concur, and really is not the reason why the market cares. I bought a lot when the 4 trial deal with CannVaLate was announced around 2c, but held an initial position earlier from last year's little trading fiasco.

The Dental Biz should be a STRENGTH not a weakness and I definitely agree with you about the cash burn. The dental biz should generate profit and increasing revenues, decreasing costs as they have been doing honestly for the past year or so. Once we are FCF+ on dental biz, and cashed up from our oppies, IHL likely wont need another CR before they start to sell MedCann products through the CannVaLate distribution network used by 230 Million MC+ Althea Group. The dental biz should be our advantage over the other medcanns and bios who make piss all revenue if not NONE and burn millions per quarter. I hope that the BOD can manage to do so in a quick timeframe, because honestly once we get that done there is practically ZERO downside from these levels.

Expand

I could read your views all day long. Your benevolence and passion not just for IHL, but to this thread is a breath of fresh air. So thank you my friend.

IHL Price at posting: 8.2¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ABY

Adore Beauty FY24 revenues up 7.4% YoY to $196M

Talking Australia's very competitive property landscape: Realty Talks

AMI

First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia

ASX Market Open: Aussie futures fall on overall weak night in the US

AI stocks: What to expect in 2024-25